FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

bruno ledergerber

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1

Concepts & Ideas

Geographic Areas

Procedures

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Rainer Weber; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; M Flepp; Hansjakob Furrer; J Kowalska; bruno ledergerber; Martin Rickenbach; M Ruppik; Patrick Schmid; A Spoerri
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.
Y Achermann; M Clauss; L Derksen; K Eigenmann; bruno ledergerber; R Nüesch; P Rafeiner; M Vogt; C Zellweger; W Zimmerli
Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study.
Helen Kovari; bruno ledergerber; Jens D Lundgren; Philippe Morlat; Kathy Petoumenos; Andrew Phillips; Peter Reiss; Lene Ryom; Caroline A Sabin; Colette Smith; Stéphane De Wit; Eric Fontas; Signe W Worm; Rainer Weber
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of bruno ledergerber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rainer Weber; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; M Flepp; Hansjakob Furrer; J Kowalska; bruno ledergerber; Martin Rickenbach; M Ruppik; Patrick Schmid; A Spoerri
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.
HIV medicine 2013;14(4):195-207.
2013: Y Achermann; M Clauss; L Derksen; K Eigenmann; bruno ledergerber; R Nüesch; P Rafeiner; M Vogt; C Zellweger; W Zimmerli
Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study.
Infection 2013;41(2):431-7.
2013: Helen Kovari; bruno ledergerber; Jens D Lundgren; Philippe Morlat; Kathy Petoumenos; Andrew Phillips; Peter Reiss; Lene Ryom; Caroline A Sabin; Colette Smith; Stéphane De Wit; Eric Fontas; Signe W Worm; Rainer Weber
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(6):870-9.
2013: Alexia Cusini; Laurent A Decosterd; Christoph A Fux; Roman Gaudenz; Huldyrich F Günthard; Chistine Gutmann; Bernhard Hirschel; Thomas Klimkait; bruno ledergerber; Milos Opravil; Janine Rohrbach; Pietro L Vernazza; Nicolas Widmer; Sabine Yerly; Franziska Zenger; Matthias Cavassini
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid.
Journal of acquired immune deficiency syndromes (1999) 2013;62(1):28-35.
2012: Tsogyal D Latshang; bruno ledergerber; Christian M Lo Cascio; Yvonne Nussbaumer-Ochsner; Silvia Ulrich; Rahel M Henn; Malcolm Kohler; Konrad E Bloch
Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2012;308(22):2390-8.
2012: Margaret T May; Gemma Navarro; Michael S Saag; Bryan E Shepherd; Paz Sobrino-Vegas; Jonathan A C Sterne; Rodolphe Thiébaut; Ard van Sighem; Jörg J Vehreschild; Dominique Costagliola; Heidi M Crane; Antonella d'Arminio Monforte; M John Gill; Jodie L Guest; Robert S Hogg; Suzanne Ingle; Amy C Justice; Ole Kirk; Fiona Lampe; bruno ledergerber
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
International journal of epidemiology 2012;41(6):1807-20.
2012: M Greiner; bruno ledergerber; A Cusini; Thomas Fehr; M Ruesch; M Schiesser; N J Mueller
A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation.
Infection 2012;40(6):669-75.
2012: Luigia Elzi; Stefan Erb; Hansjakob Furrer; Bernard Hirschel; bruno ledergerber; Pietro Vernazza; Rainer Weber; Manuel Battegay; Enos Bernasconi; Matthias Cavassini
Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes.
Archives of internal medicine 2012;172(17):1313-21.
2012: M Huber; R Jaccard; bruno ledergerber; Dunja Nicca; C Orasch; R Sauter; Rainer Weber; Jim Young; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; A Cusini; J Fehr; L Held
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians.
HIV medicine 2012;13(7):387-97.
2012: Julia Braun; Leonhard Held; bruno ledergerber
Predictive cross-validation for the choice of linear mixed-effects models with application to data from the Swiss HIV Cohort Study.
Biometrics 2012;68(1):53-61.
2012: Satish K Pillai; Andri Rauch; Mark Skasko; Andrea Witteck; Joseph Wong; Steven Yukl; Mohamed Abdel-Mohsen; Manuel Battegay; Enos Bernasconi; Jacques Fellay; Katsuya Fujimoto; Warner C Greene; John C Guatelli; Huldrych Günthard; Bernard Hirschel; Helen Kovari; bruno ledergerber; Alexander Monto
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(8):3035-40.
2012: C Thierfelder; Rainer Weber; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; C Gutmann; bruno ledergerber
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.
HIV medicine 2012;13(2):118-26.
2012: Alexandra U Scherrer; Viktor von Wyl; Sabine Yerly; Jürg Böni; Cristina Cellerai; Matthias Götte; Huldrych Günthard; Leonhard Held; Thomas Klimkait; bruno ledergerber
Polymorphic mutations associated with the emergence of the multinucleoside/tide resistance mutations 69 insertion and Q151M.
Journal of acquired immune deficiency syndromes (1999) 2012;59(2):105-12.
2012: Olivia Keiser; bruno ledergerber; Dunja Nicca; Andri Rauch; Ben Spycher; Alexandra Calmy; Matthias Cavassini; Matthias Egger; Tracy R Glass
Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis.
AIDS and behavior 2012;16(2):245-55.
2012: Justyna D Kowalska; bruno ledergerber; Jens D Lundgren; Amanda Mocroft; Andrew Phillips; Joanne Reekie; Peter Reiss; Antonella d'Arminio Monforte; Jose Gatell; Ole Kirk
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.
AIDS (London, England) 2012;26(3):315-23.
2012: Joshua T Herbeck; Lisa P Jacobson; bruno ledergerber; Brandon S Maust; Viktor Müller; James I Mullins; Carlo Torti; Simona Di Giambenedetto; Luuk Gras; Huldrych Günthard; Geoffrey S Gottlieb
Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.
AIDS (London, England) 2012;26(2):193-205.
2012: Alexandra U Scherrer; Pietro L Vernazza; Sabine Yerly; Vincent Aubert; Enos Bernasconi; Jürg Böni; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; Huldrych F Günthard; Thomas Klimkait; bruno ledergerber
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
PloS one 2012;7(11):e50307.
2012: Daniel A Duprez; Lewis H Kuller; H Clifford Lane; bruno ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas Paton; Ronald J Prineas; Russell Tracy; James D Neaton; Waldo H Belloso; Stephane De Wit; Fraser Drummond
Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.
PloS one 2012;7(9):e44454.
2012: Alexandra U Scherrer; Pietro L Vernazza; Viktor von Wyl; Sabine Yerly; Enos Bernasconi; Jürg Böni; Alexandra Calmy; Matthias Cavassini; Cristina Cellerai; Luigia Elzi; Hansjakob Furrer; Huldrych Günthard; Thomas Klimkait; bruno ledergerber
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
PloS one 2012;7(6):e37983.
2012: Viktor von Wyl; Sabine Yerly; Manuel Battegay; Enos Bernasconi; Jürg Böni; Matthias Cavassini; Cristina Cellerai; Hansjakob Furrer; Huldrych Günthard; Bernard Hirschel; Thomas Klimkait; bruno ledergerber; Cyril Shah; Pietro L Vernazza
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(1):131-40.
2011: A-M Giner; S P Kuster; bruno ledergerber; C Ruef; Reinhard Zbinden; Rainer Weber
Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003-2009.
Infection 2011;39(6):519-26.
2011: Anna Haas; Bernard Hirschel; bruno ledergerber; Andrew J Macpherson; Annette Oxenius; Nicola Patuto; Peter Rusert; Emma Slack; Maria C Thurnheer; Pietro Vernazza; Rainer Weber; Kathrin Zimmermann; Manuel Battegay; Walter Bossart; Frederik Graw; Huldrych F Günthard
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection.
Gut 2011;60(11):1506-19.
2011: Kjetil Røysland; Jim Young; Viktor von Wyl; Jon Michael Gran; bruno ledergerber; Odd O Aalen
Analyzing direct and indirect effects of treatment using dynamic path analysis applied to data from the Swiss HIV Cohort Study.
Statistics in medicine 2011;30(24):2947-58.
2011: Viktor von Wyl; Rainer Weber; Sabine Yerly; Manuel Battegay; Enos Bernasconi; Sebastian Bonhoeffer; Jürg Böni; Philippe Bürgisser; Matthias Cavassini; Huldrych Günthard; Bernard Hirschel; Thomas Klimkait; Roger D Kouyos; bruno ledergerber; Cyril Shah; Cornelia Staehelin; Pietro L Vernazza
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland.
The Journal of infectious diseases 2011;204(7):1095-103.
2011: Alexandra U Scherrer; Pietro L Vernazza; Viktor von Wyl; Sabine Yerly; Manuel Battegay; Enos Bernasconi; Jürg Böni; Philippe Bürgisser; Matthias Cavassini; Christian Garzoni; Huldrych F Günthard; Bernard Hirschel; Thomas Klimkait; bruno ledergerber
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors.
Journal of acquired immune deficiency syndromes (1999) 2011;57(1):24-31.
2011: bruno ledergerber; Matthias Cavassini; Manuel Battegay; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel; Hansjakob Furrer; Martin Rickenbach; Rainer Weber
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
HIV medicine 2011;12(5):279-88.
2011: J Reekie; Peter Reiss; bruno ledergerber; D Sedlacek; M Parczewski; J Gatell; Christine Katlama; G Fätkenheuer; Amanda Mocroft; J D Lundgren
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.
HIV medicine 2011;12(5):259-68.
2011: Alexandra U Scherrer; Viktor von Wyl; Beda Joos; Thomas Klimkait; Philippe Bürgisser; Sabine Yerly; Jürg Böni; bruno ledergerber; Huldrych Günthard
Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study.
The Journal of infectious diseases 2011;203(6):791-7.
2011: Justyna D Kowalska; Amanda Mocroft; bruno ledergerber; Eric Florence; Matti Ristola; Josip Begovac; Helen Sambatakou; Court Pedersen; Jens D Lundgren; Ole Kirk
A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.
HIV clinical trials 2011;12(2):109-17.
2011: Millán Ortiz; Estella S Poloni; Hansjakob Furrer; Helen Kovari; Raquel Martinez; Mireia Arnedo; Luigia Elzi; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel; Matthias Cavassini; bruno ledergerber; Huldrych Günthard; Amalio Telenti; Philip E Tarr
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.
The Journal of infectious diseases 2011;203(5):620-4.
2011: Roger D Kouyos; Viktor von Wyl; Sabine Yerly; Jürg Böni; Philip Rieder; Beda Joos; Patrick Taffé; Cyril Shah; Philippe Bürgisser; Thomas Klimkait; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Andri Rauch; Manuel Battegay; Pietro L Vernazza; Enos Bernasconi; bruno ledergerber; Sebastian Bonhoeffer; Huldrych Günthard
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(4):532-9.
2011: Rubin Lubomirov; Sara Colombo; Julia di Iulio; bruno ledergerber; Raquel Martinez; Matthias Cavassini; Bernard Hirschel; Enos Bernasconi; Luigia Elzi; Pietro Vernazza; Hansjakob Furrer; Huldrych Günthard; Amalio Telenti
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.
The Journal of infectious diseases 2011;203(2):246-57.
2011: Jim Young; Marina B Klein; bruno ledergerber
Noncirrhotic portal hypertension and didanosine: a re-analysis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(1):154-5.
2011: Jason V Baker; Jacqueline Neuhaus; Daniel Duprez; Lewis H Kuller; Russell Tracy; Waldo H Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; bruno ledergerber; Jens Lundgren; Daniel E Nixon; Nicholas Paton; James D Neaton
Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.
Journal of acquired immune deficiency syndromes (1999) 2011;56(1):36-43.
2010: Barbara Hasse; bruno ledergerber; Bernard Hirschel; Pietro Vernazza; Tracy R Glass; André Jeannin; John-Marc Evison; Luigia Elzi; Matthias Cavassini; Enos Bernasconi; Dunja Nicca; Rainer Weber
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(11):1314-22.
2010: Jon Michael Gran; Kjetil Røysland; Marcel Wolbers; Vanessa Didelez; Jonathan A C Sterne; bruno ledergerber; Hansjakob Furrer; Viktor von Wyl; Odd O Aalen
A sequential Cox approach for estimating the causal effect of treatment in the presence of time-dependent confounding applied to data from the Swiss HIV Cohort Study.
Statistics in medicine 2010;29(26):2757-68.
2010: Margalida Rotger; Thomas Gsponer; Raquel Martinez; Patrick Taffé; Luigia Elzi; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Bernard Hirschel; Hansjakob Furrer; Rainer Weber; bruno ledergerber; Matthias Egger; Amalio Telenti; Philip E Tarr
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(9):1090-8.
2010: Amanda Mocroft; Peter Reiss; Jacek Gasiorowski; bruno ledergerber; Justyna Kowalska; Antonio Chiesi; Jose Gatell; Aza Rakhmanova; Margaret Johnson; Ole Kirk; Jens Lundgren
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.
Journal of acquired immune deficiency syndromes (1999) 2010;55(2):262-70.
2010: Franziska Schoeni-Affolter; bruno ledergerber; Martin Rickenbach; Christoph Rudin; Huldrych F Günthard; Amalio Telenti; Hansjakob Furrer; Sabine Yerly; Patrick Francioli
Cohort profile: the Swiss HIV Cohort study.
International journal of epidemiology 2010;39(5):1179-89.
2010: Viktor von Wyl; Maryam Ehteshami; Lisa M Demeter; Philippe Bürgisser; Monique Nijhuis; Jori Symons; Sabine Yerly; Jürg Böni; Thomas Klimkait; Rob Schuurman; bruno ledergerber; Matthias Götte; Huldrych F Günthard
HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(5):620-8.
2010: J Reekie; Amanda Mocroft; bruno ledergerber; Marek Beniowski; Bonaventura Clotet; J van Lunzen; Antonio Chiesi; Christian Pradier; L Machala; Jens D Lundgren
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.
HIV medicine 2010;11(7):469-78.
2010: Rebecca K Lodwick; Caroline A Sabin; Kholoud Porter; bruno ledergerber; Ard van Sighem; Alessandro Cozzi-Lepri; Pavel Khaykin; Amanda Mocroft; Lisa P Jacobson; Stephane De Wit; Niels Obel; Antonella Castagna; Jan-Christian Wasmuth; John Gill; Marina B Klein; Stephen J Gange; Melchor Riera; Cristina Mussini; Félix Gutiérrez; Giota Touloumi; Patrizia Carrieri; Jodie L Guest; Norbert H Brockmeyer; Andrew N Phillips
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
Lancet 2010;376(9738):340-5.
2010: Silvia Franceschi; M Lise; Gary M Clifford; Martin Rickenbach; Fabio Levi; M Maspoli; Christine Bouchardy; S Dehler; Gernot Jundt; S Ess; A Bordoni; I Konzelmann; H Frick; Luigino Dal Maso; L Elzi; Hansjakob Furrer; A Calmy; Matthias Cavassini; bruno ledergerber; Olivia Keiser
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
British journal of cancer 2010;103(3):416-22.
2010: Amanda Mocroft; Ole Kirk; Peter Reiss; Stephane De Wit; Dalibor Sedlacek; Marek Beniowski; Jose Gatell; Andrew N Phillips; bruno ledergerber; Jens D Lundgren
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
AIDS (London, England) 2010;24(11):1667-78.
2010: Roger D Kouyos; Viktor von Wyl; Sabine Yerly; Jürg Böni; Patrick Taffé; Cyril Shah; Philippe Bürgisser; Thomas Klimkait; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Hansjakob Furrer; Manuel Battegay; Pietro L Vernazza; Enos Bernasconi; Martin Rickenbach; bruno ledergerber; Sebastian Bonhoeffer; Huldrych Günthard
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.
The Journal of infectious diseases 2010;201(10):1488-97.
2010: Nicolas Mueller; Christoph A Fux; bruno ledergerber; Luigia Elzi; Patrick Schmid; Thanh Dang; Lorenzo Magenta; Alexandra Calmy; Athanasios Vergopoulos; Heike A Bischoff-Ferrari
High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients.
AIDS (London, England) 2010;24(8):1127-34.
2010: Viktor von Wyl; Maryam Ehteshami; Jori Symons; Philippe Bürgisser; Monique Nijhuis; Lisa M Demeter; Sabine Yerly; Jürg Böni; Thomas Klimkait; Rob Schuurman; bruno ledergerber; Matthias Götte; Huldrych Günthard
Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase.
The Journal of infectious diseases 2010;201(7):1054-62.
2010: Rubin Lubomirov; Julia di Iulio; Aurélie Fayet; Sara Colombo; Raquel Martinez; Catia Marzolini; Hansjakob Furrer; Pietro Vernazza; Alexandra Calmy; Matthias Cavassini; bruno ledergerber; Katharina Rentsch; Patrick Descombes; Thierry Buclin; Laurent A Decosterd; Chantal Csajka; Amalio Telenti
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
Pharmacogenetics and genomics 2010;20(4):217-30.
2010: Alexandra U Scherrer; Viktor von Wyl; Christof A Fux; Milos Opravil; Heiner C Bucher; Aurélie Fayet; Laurent A Decosterd; Bernhard Hirschel; B Khanlari; Sabine Yerly; Thomas Klimkait; Hansjakob Furrer; bruno ledergerber; Huldrych Günthard
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures.
Journal of acquired immune deficiency syndromes (1999) 2010;53(4):464-71.
2010: Helen Kovari; bruno ledergerber; Manuel Battegay; Andri Rauch; Bernard Hirschel; Alain Kenfak Foguena; Pietro Vernazza; Enos Bernasconi; Nicolas J Mueller; Rainer Weber
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(4):502-11.
2010: S P Kuster; Barbara Hasse; V Huebner; V Bansal; Reinhard Zbinden; C Ruef; bruno ledergerber; Rainer Weber
Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland.
Infection 2010;38(1):33-40.
2010: S Gianella; L Haeberli; Beda Joos; bruno ledergerber; R P Wüthrich; Rainer Weber; Herbert Kuster; P M Hauser; Thomas Fehr; Nicolas Mueller
Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society 2010;12(1):1-10.
2010: Luigia Elzi; Catia Marzolini; Hansjakob Furrer; bruno ledergerber; Matthias Cavassini; Bernard Hirschel; Pietro Vernazza; Enos Bernasconi; Rainer Weber; Manuel Battegay
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Archives of internal medicine 2010;170(1):57-65.
2010: Rainer Weber; Caroline Sabin; Peter Reiss; Stephane de Wit; Signe W Worm; Matthew Law; Francois Dabis; Antonella d'Arminio Monforte; Eric Fontas; Wafaa El-Sadr; Ole Kirk; Martin Rickenbach; Andrew Phillips; bruno ledergerber; Jens Lundgren
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study.
Antiviral therapy 2010;15(8):1077-86.
2010: Alexia Cusini; Silvana K Rampini; Vineeta Bansal; bruno ledergerber; Stefan P Kuster; Christian Ruef; Rainer Weber
Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey.
PloS one 2010;5(11):e14011.
2010: Amanda Mocroft; Andrew N Phillips; bruno ledergerber; Colette Smith; Johannes R Bogner; Karine Lacombe; Alicje Wiercinska-Drapalo; Peter Reiss; Ole Kirk; Jens D Lundgren
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy.
Antiviral therapy 2010;15(4):563-70.
2010: Catia Marzolini; Luigia Elzi; Sara Gibbons; Rainer Weber; Christoph Fux; Hansjakob Furrer; Jean-Philippe Chave; Matthias Cavassini; Enos Bernasconi; Alexandra Calmy; Pietro Vernazza; Saye Khoo; bruno ledergerber; David Back; Manuel Battegay
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Antiviral therapy 2010;15(3):413-23.
2009: Margalida Rotger; Cornelia Bayard; Patrick Taffé; Raquel Martinez; Matthias Cavassini; Enos Bernasconi; Manuel Battegay; Bernard Hirschel; Hansjakob Furrer; Andrea Witteck; Rainer Weber; bruno ledergerber; Amalio Telenti; Philip E Tarr
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Circulation. Cardiovascular genetics 2009;2(6):621-8.
2009: A U Scherrer; Barbara Hasse; Viktor von Wyl; Sabine Yerly; Jürg Böni; Philippe Bürgisser; Thomas Klimkait; Heiner C Bucher; bruno ledergerber; Huldrych Günthard
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS).
HIV medicine 2009;10(10):647-56.
2009: Christophe Combescure; N Vallier; bruno ledergerber; Matthias Cavassini; Hansjakob Furrer; A Rauch; Manuel Battegay; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel
How reliable is an undetectable viral load?
HIV medicine 2009;10(8):470-6.
2009: Helen Kovari; bruno ledergerber; Ulrich Peter; Markus Flepp; Josef Jost; Patrick Schmid; Alexandra Calmy; Nicolas J Mueller; Beat Muellhaupt; Rainer Weber
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(4):626-35.
2009: Rainer Weber; M Huber; Martin Rickenbach; Hansjakob Furrer; Luigia Elzi; Bernard Hirschel; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; bruno ledergerber
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
HIV medicine 2009;10(7):407-16.
2009: Viktor Müller; Viktor von Wyl; Sabine Yerly; Jürg Böni; Thomas Klimkait; Philippe Bürgisser; bruno ledergerber; Huldrych Günthard; Sebastian Bonhoeffer
African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study.
AIDS (London, England) 2009;23(10):1269-76.
2009: Lars Peters; Amanda Mocroft; Vincent Soriano; Jürgen K Rockstroh; Marcelo Losso; Laure Valerio; Pauls Aldins; Peter Reiss; bruno ledergerber; Jens D Lundgren
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.
Journal of acquired immune deficiency syndromes (1999) 2009;50(5):457-63.
2009: Viktor von Wyl; Sabine Yerly; Philippe Bürgisser; Thomas Klimkait; Manuel Battegay; Enos Bernasconi; Matthias Cavassini; Hansjakob Furrer; Bernard Hirschel; Pietro L Vernazza; Patrick Francioli; Sebastian Bonhoeffer; bruno ledergerber; Huldrych Günthard
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(7):979-87.
2009: Andreas J Flammer; N T T Vo; bruno ledergerber; Frank Hermann; A Gämperli; A Huttner; J Evison; Iris Baumgartner; Matthias Cavassini; Daniel Hayoz; Kurt Quitzau; Martin Hersberger; Isabella Sudano; Frank Ruschitzka; Thomas F Lüscher; Georg Noll; Rainer Weber
Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial.
Heart (British Cardiac Society) 2009;95(5):385-90.
2009: Marie Ballif; bruno ledergerber; Manuel Battegay; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; Bernard Hirschel; Hansjakob Furrer; Martin Rickenbach; Milos Opravil; Rainer Weber
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
PloS one 2009;4(12):e8275.
2008: S P Kuster; C Ruef; bruno ledergerber; A Hintermann; C Deplazes; L Neuber; Rainer Weber
Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting.
Infection 2008;36(6):549-59.
2008: Stefan P Kuster; Christian Ruef; Reinhard Zbinden; Jochen Gottschalk; bruno ledergerber; Lutz Neuber; Rainer Weber
Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay.
The Journal of antimicrobial chemotherapy 2008;62(6):1451-61.
2008: Vincent Soriano; Amanda Mocroft; Juergen Rockstroh; bruno ledergerber; Brygida Knysz; Saulius Chaplinskas; Lars Peters; Anders Karlsson; Christine Katlama; Carlos Toro; Bernd Kupfer; Martin Vogel; Jens Lundgren
Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
The Journal of infectious diseases 2008;198(9):1337-44.
2008: Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; bruno ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas Paton; James D Neaton
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
PLoS medicine 2008;5(10):e203.
2008: Gary M Clifford; Martin Rickenbach; Jerry Polesel; Luigino Dal Maso; Ingrid Steffen; bruno ledergerber; Andri Rauch; Nicole M Probst-Hensch; Christine Bouchardy; Fabio Levi; Silvia Franceschi
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
AIDS (London, England) 2008;22(16):2135-41.
2008: Stefan P Kuster; Christian Ruef; A Bollinger; bruno ledergerber; Andreas Hintermann; Clau Deplazes; Lutz Neuber; Rainer Weber
Correlation between case mix index and antibiotic use in hospitals.
The Journal of antimicrobial chemotherapy 2008;62(4):837-42.
2008: Olivia Keiser; Catherine Orrell; Matthias Egger; Robin Wood; Martin W G Brinkhof; Hansjakob Furrer; Gilles Van Cutsem; bruno ledergerber; Andrew Boulle
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared.
PLoS medicine 2008;5(7):e148.
2008: Thi Tuyet Nhung Vo; bruno ledergerber; Olivia Keiser; Bernard Hirschel; Hansjakob Furrer; Manuel Battegay; Matthias Cavassini; Enos Bernasconi; Pietro Vernazza; Rainer Weber
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.
The Journal of infectious diseases 2008;197(12):1685-94.
2008: Viktor von Wyl; Sabine Yerly; Jürg Böni; Philippe Bürgisser; Thomas Klimkait; Manuel Battegay; Enos Bernasconi; Matthias Cavassini; Hansjakob Furrer; Bernard Hirschel; Pietro L Vernazza; Martin Rickenbach; bruno ledergerber; Huldrych Günthard
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(8):1299-309.
2008: Simona Berger; Tanja Schad; Viktor von Wyl; Ulrike Ehlert; Claudine Zellweger; Hansjakob Furrer; Daniel Regli; Pietro Vernazza; bruno ledergerber; Manuel Battegay; Rainer Weber; Jens Gaab
Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons.
AIDS (London, England) 2008;22(6):767-75.
2008: Barbara Weiser; Sean Philpott; Thomas Klimkait; Harold Burger; Christina Kitchen; Philippe Bürgisser; Meri Gorgievski; Luc Perrin; Jean-Claude Piffaretti; bruno ledergerber
HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy.
AIDS (London, England) 2008;22(4):469-79.
2007: Margaret May; Jonathan A C Sterne; Martin Shipley; Eric Brunner; Ralph d'Agostino; Peter H Whincup; Yoav Ben-Shlomo; Andrew Carr; bruno ledergerber; Jens D Lundgren; Andrew N Phillips; Joseph Massaro; Matthias Egger
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men.
International journal of epidemiology 2007;36(6):1309-18.
2007: Sabine Yerly; Viktor von Wyl; bruno ledergerber; Jürg Böni; Jörg Schüpbach; Philippe Bürgisser; Thomas Klimkait; Martin Rickenbach; Laurent Kaiser; Huldrych Günthard; Luc Perrin
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
AIDS (London, England) 2007;21(16):2223-9.
2007: Amanda Mocroft; bruno ledergerber; Kai Zilmer; Ole Kirk; Bernard Hirschel; Jean-Paul Viard; Peter Reiss; Patrick Francioli; Adriano Lazzarin; Ladislav Machala; Andrew N Phillips; Jens D Lundgren
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
AIDS (London, England) 2007;21(14):1867-75.
2007: Viktor von Wyl; Sabine Yerly; Jürg Böni; Philippe Bürgisser; Thomas Klimkait; Manuel Battegay; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Pietro L Vernazza; Enos Bernasconi; Martin Rickenbach; Luc Perrin; bruno ledergerber; Huldrych Günthard
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.
Archives of internal medicine 2007;167(16):1782-90.
2007: Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; bruno ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; Jose M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
A whole-genome association study of major determinants for host control of HIV-1.
Science (New York, N.Y.) 2007;317(5840):944-7.
2007: Amanda Mocroft; Andrew N Phillips; José M Gatell; bruno ledergerber; Martin Fisher; Nathan Clumeck; Marcelo H Losso; Adriano Lazzarin; G Fatkenheuer; Jens D Lundgren
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Lancet 2007;370(9585):407-13.
2007: bruno ledergerber; Hansjakob Furrer; Martin Rickenbach; Roger Lehmann; Luigia Elzi; Bernard Hirschel; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; Matthias Egger; Rainer Weber
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(1):111-9.
2007: Margaret May; Jonathan A C Sterne; Caroline Sabin; Dominique Costagliola; Amy C Justice; Rodolphe Thiébaut; John Gill; Andrew Phillips; Peter Reiss; Hogg Robert; bruno ledergerber; Antonella d'Arminio Monforte; Norbert Schmeisser; Schlomo Staszewski; Matthias Egger
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.
AIDS (London, England) 2007;21(9):1185-97.
2007: Jonathan A C Sterne; M May; Heiner C Bucher; bruno ledergerber; H Furrer; M Cavassini; E Bernasconi; Bernard Hirschel; Matthias Egger
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy.
Journal of internal medicine 2007;261(3):255-67.
2007: Pedram Sendi; Huldrych Günthard; Mathew Simcock; bruno ledergerber; Jörg Schüpbach; Manuel Battegay
Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.
PloS one 2007;2(1):e173.
2006: Silvia Franceschi; Jerry Polesel; Martin Rickenbach; Luigino Dal Maso; Nicole M Probst-Hensch; C Fux; Matthias Cavassini; Barbara Hasse; Andreas Kofler; bruno ledergerber; Peter Erb; Gary M Clifford
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study.
British journal of cancer 2006;95(11):1598-602.
2006: Daria Podlekareva; Amanda Mocroft; Ulrik B Dragsted; bruno ledergerber; Marek Beniowski; Adriano Lazzarin; Jonathan Weber; Nathan Clumeck; Norbert Vetter; Andrew Phillips; Jens D Lundgren
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.
The Journal of infectious diseases 2006;194(5):633-41.
2006: Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; François Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; bruno ledergerber; Andrew N Phillips; Jens D Lundgren
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.
Archives of internal medicine 2006;166(15):1632-41.
2006: Amanda Mocroft; Andrew N Phillips; bruno ledergerber; Christine Katlama; Antonio Chiesi; Frank-Detlef Goebel; Brygida Knysz; Francisco Antunes; Peter Reiss; Jens D Lundgren
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
AIDS (London, England) 2006;20(8):1141-50.
2006: Viktor Müller; bruno ledergerber; Luc Perrin; Thomas Klimkait; Hansjakob Furrer; Amalio Telenti; Enos Bernasconi; Pietro Vernazza; Huldrych Günthard; Sebastian Bonhoeffer
Stable virulence levels in the HIV epidemic of Switzerland over two decades.
AIDS (London, England) 2006;20(6):889-94.
2006: Massimo Puoti; Alessandro Cozzi-Lepri; Giuseppe Paraninfo; Claudio Arici; Nina Friis Moller; Jens D Lundgren; bruno ledergerber; Martin Rickenbach; Ignacio Suarez-Lozano; Myriam Garrido; François Dabis; Maria Winnock; Laura Milazzo; Anne Gervais; Francois Raffi; John Gill; Jürgen Rockstroh; Nazifa Ourishi; Cristina Mussini; Antonella Castagna; Andrea De Luca; Antonella d'Arminio Monforte
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis.
Antiviral therapy 2006;11(5):567-74.
2006: Mathew Simcock; Pedram Sendi; bruno ledergerber; Tamara Keller; Jörg Schüpbach; Manuel Battegay; Huldrych Günthard
A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off?
Antiviral therapy 2006;11(3):305-14.
2006: Annelies S Zinkernagel; Viktor von Wyl; bruno ledergerber; Martin Rickenbach; Hansjakob Furrer; Manuel Battegay; Bernard Hirschel; Philip E Tarr; Milos Opravil; Enos Bernasconi; Patrick Schmid; Rainer Weber
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study.
Antiviral therapy 2006;11(2):131-42.
2006: David Hürlimann; Rémy Chenevard; Frank Ruschitzka; M Flepp; Frank Enseleit; Markus Béchir; Richard Kobza; Jörg Muntwyler; bruno ledergerber; Thomas F Lüscher; Georg Noll; R Weber
Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial.
Heart (British Cardiac Society) 2006;92(1):110-2.
2005: Urs Karrer; bruno ledergerber; Hansjakob Furrer; Luigia Elzi; Manuel Battegay; Matthias Cavassini; Angèle Gayet-Ageron; Bernard Hirschel; Patrick Schmid; Marina Russotti; Rainer Weber; Roberto F Speck
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir.
AIDS (London, England) 2005;19(17):1987-94.
2005: Jürgen K Rockstroh; Amanda Mocroft; Vincent Soriano; Cristina Tural; Marcello H Losso; Andrzej Horban; Ole Kirk; Andrew Phillips; bruno ledergerber; Jens Lundgren
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
The Journal of infectious diseases 2005;192(6):992-1002.
2005: Alexander Imhof; bruno ledergerber; Huldrych Günthard; Stefan Haupts; Rainer Weber
Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(5):721-8.
2005: A Lowy; J Page; R Jaccard; bruno ledergerber; B Somaini; Rainer Weber; T Szucs
Costs of treatment of Swiss patients with HIV on antiretroviral therapy in hospital-based and general practice-based care: a prospective cohort study.
AIDS care 2005;17(6):698-710.
2005: Gilbert R Kaufmann; Hansjakob Furrer; bruno ledergerber; Luc Perrin; Milos Opravil; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Martin Rickenbach; Bernard Hirschel; Manuel Battegay
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(3):361-72.
2005: Jonathan A C Sterne; Miguel A Hernán; bruno ledergerber; Kate Tilling; Rainer Weber; Pedram Sendi; Martin Rickenbach; James M Robins; Matthias Egger
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.
Lancet 2005;366(9483):378-84.
2005: Philip E Tarr; Patrick Taffé; Gabriela Bleiber; Hansjakob Furrer; Margalida Rotger; Raquel Martinez; Bernard Hirschel; Manuel Battegay; Rainer Weber; Pietro Vernazza; Enos Bernasconi; Roger Darioli; Martin Rickenbach; bruno ledergerber; Amalio Telenti
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
The Journal of infectious diseases 2005;191(9):1419-26.
2005: Deborah Konopnicki; Amanda Mocroft; Stéphane De Wit; Francisco Antunes; bruno ledergerber; Christine Katlama; K Zilmer; STEFANO VELLA; Ole Kirk; Jens D Lundgren
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.
AIDS (London, England) 2005;19(6):593-601.
2005: Antonella d'Arminio Monforte; Caroline A Sabin; Andrew Phillips; Jonathan A C Sterne; Margaret May; Amy Justice; François Dabis; Sophie Grabar; bruno ledergerber; John Gill; Peter Reiss; Matthias Egger
The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.
Archives of internal medicine 2005;165(4):416-23.
2005: Christian Holkmann Olsen; José M Gatell; bruno ledergerber; Christine Katlama; Nina Friis-Møller; Jonathan Weber; Andrzej Horban; Schlomo Staszewski; Jens D Lundgren; Andrew N Phillips
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
AIDS (London, England) 2005;19(3):319-30.
2005: Alessandro Cozzi-Lepri; Lidia Ruiz; Clive Loveday; Andrew N Phillips; Bonaventura Clotet; Peter Reiss; bruno ledergerber; Christian Holkmann; Schlomo Staszewski; Jens D Lundgren
Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapy.
Antiviral therapy 2005;10(7):791-802.
2005: Amanda Mocroft; Jürgen Rockstroh; Vincent Soriano; bruno ledergerber; Ole Kirk; Elena Vinogradova; Peter Reiss; Christine Katlama; Andrew N Phillips; Jens D Lundgren
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?
Antiviral therapy 2005;10(7):779-90.
2004: Amanda Mocroft; bruno ledergerber; Jean-Paul Viard; Schlomo Staszewski; M Murphy; Antonio Chiesi; Andrzej Horban; Ann-Brit Eg Hansen; Andrew N Phillips; Jens D Lundgren
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group.
The Journal of infectious diseases 2004;190(11):1947-56.
2004: Amanda Mocroft; José M Gatell; Peter Reiss; bruno ledergerber; Ole Kirk; STEFANO VELLA; Anders Blaxhult; Andrew N Phillips; Jens Lundgren
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.
AIDS (London, England) 2004;18(17):2333-7.
2004: Milos Opravil; Doris Baumann; Jean-Philippe Chave; Hansjakob Furrer; Alexandra Calmy; Enos Bernasconi; Monika Blasko; Pietro Vernazza; bruno ledergerber; Luc Perrin
Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine.
AIDS (London, England) 2004;18(16):2213-5.
2004: Cecilia Cabrera; Alessandro Cozzi-Lepri; Andrew N Phillips; Clive Loveday; Ole Kirk; Mounir Ait-Khaled; Peter Reiss; Jesper Kjaer; bruno ledergerber; Jens D Lundgren; Bonaventura Clotet; Lidia Ruiz
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.
Antiviral therapy 2004;9(5):787-800.
2004: M Flepp; bruno ledergerber
[The Swiss HIV Cohort Study--multifaceted network supporting patient care as well as large international research projects].
Therapeutische Umschau. Revue thérapeutique 2004;61(10):635-8.
2004: Andrew N Phillips; bruno ledergerber; Andrzej Horban; Peter Reiss; Antonio Chiesi; Ole Kirk; Fiona Mulchany; Martin Fisher; Ladislav Machala; Jens D Lundgren
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression.
AIDS (London, England) 2004;18(13):1795-804.
2004: Barbara Hasse; bruno ledergerber; Matthias Egger; Markus Flepp; Stefano Bachmann; Enos Bernasconi; Martin Egger; Sophie Guyot; Bernard Hirschel; Rainer Weber; Huldrych Günthard
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study.
AIDS research and human retroviruses 2004;20(9):909-15.
2004: Martin Hersberger; Sebastian Bonhoeffer; S K Rampini; Milos Opravil; Jacqueline Marti-Jaun; Amalio Telenti; Edgar Hänseler; bruno ledergerber; Roberto F Speck
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis.
Clinical and experimental immunology 2004;137(3):566-9.
2004: Jesper Kjaer; bruno ledergerber
HIV cohort collaborations: proposal for harmonization of data exchange.
Antiviral therapy 2004;9(4):631-3.
2004: bruno ledergerber; Jens D Lundgren; A Sarah Walker; Caroline Sabin; Amy Justice; Peter Reiss; Cristina Mussini; Ferdinand Wit; Antonella d'Arminio Monforte; Rainer Weber; Gregory Fusco; Schlomo Staszewski; Matthew Law; Hogg Robert; Fiona Lampe; M John Gill; Francesco Castelli; Andrew N Phillips
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Lancet 2004;364(9428):51-62.
2004: I Yust; Zoe Fox; M Burke; A Johnson; D Turner; Amanda Mocroft; Christine Katlama; bruno ledergerber; P Reiss; Ole Kirk
Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(7):550-9.
2004: Jean-Philippe Zuber; Alexandra Calmy; John M Evison; Barbara Hasse; Veronique Schiffer; Thomas Wagels; Reto Nüesch; Lorenzo Magenta; bruno ledergerber; Rolf Jenni; Rudolf Speich; Milos Opravil
Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(8):1178-85.
2004: Gilbert R Kaufmann; Nina Khanna; Rainer Weber; Luc Perrin; Hansjakob Furrer; Matthias Cavassini; bruno ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Bernard Hirschel; Manuel Battegay
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.
Antiviral therapy 2004;9(2):263-74.
2004: Rainer Weber; Lisanne Christen; Stephan Christen; Simone Tschopp; Hansjoerg Znoj; Christine Schneider; Joachim Schmitt; Milos Opravil; Huldrych Günthard; bruno ledergerber
Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial.
Antiviral therapy 2004;9(1):85-95.
2003: Cornelia Staehelin; Martin Rickenbach; Nicola Low; Matthias Egger; bruno ledergerber; Bernard Hirschel; Valérie D'Acremont; Manuel Battegay; Thomas Wagels; Enos Bernasconi; Christine Kopp; Hansjakob Furrer
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.
AIDS (London, England) 2003;17(15):2237-44.
2003: Gilbert R Kaufmann; Luc Perrin; Guiseppe Pantaleo; Milos Opravil; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; bruno ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Matthias Egger; Manuel Battegay
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Archives of internal medicine 2003;163(18):2187-95.
2003: Stefan Haupts; bruno ledergerber; Jürg Böni; Jörg Schüpbach; Andreas Kronenberg; Milos Opravil; Markus Flepp; Roberto F Speck; Christina Grube; Katharina M Rentsch; Rainer Weber; Huldrych Günthard
Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
Antiviral therapy 2003;8(5):443-54.
2003: Christian Jaggy; Jan von Overbeck; bruno ledergerber; Claude Schwarz; Matthias Egger; Martin Rickenbach; Hans-Jakob Furrer; Amalio Telenti; Manuel Battegay; Markus Flepp; Pietro Vernazza; Enos Bernasconi; Bernard Hirschel
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.
Lancet 2003;362(9387):877-8.
2003: Geneviève Chêne; Jonathan A C Sterne; Margaret May; Dominique Costagliola; bruno ledergerber; Andrew N Phillips; François Dabis; J Lundgren; Antonella d'Arminio Monforte; F de Wolf; Hogg Robert; Peter Reiss; Amy Justice; Catherine Leport; Schlomo Staszewski; John Gill; G Fatkenheuer; Matthias Egger
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.
Lancet 2003;362(9385):679-86.
2003: Amanda Mocroft; Lidia Ruiz; Peter Reiss; bruno ledergerber; Christine Katlama; Adriano Lazzarin; Frank-Detlef Goebel; Andrew N Phillips; Bonaventura Clotet; Jens D Lundgren
Virological rebound after suppression on highly active antiretroviral therapy.
AIDS (London, England) 2003;17(12):1741-51.
2003: Amanda Mocroft; bruno ledergerber; Christine Katlama; Ole Kirk; Peter Reiss; Antonella d'Arminio Monforte; Brygida Knysz; M Dietrich; Andrew N Phillips; Jens D Lundgren
Decline in the AIDS and death rates in the EuroSIDA study: an observational study.
Lancet 2003;362(9377):22-9.
2003: Jörg Schüpbach; Jürg Böni; Leslie Bisset; Zuzana Tomasik; Marek Fischer; Huldrych Günthard; bruno ledergerber; Milos Opravil
HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;33(3):292-9.
2003: Alessandro Cozzi-Lepri; Andrew N Phillips; Veronica Miller; Christine Katlama; bruno ledergerber; STEFANO VELLA; Jonathan Weber; Johan Bruun; Ole Kirk; Bonaventura Clotet; Jens D Lundgrens
Changes in viral load in people with virological failure who remain on the same HAART regimen.
Antiviral therapy 2003;8(2):127-36.
2002: Gilbert Greub; Alessandro Cozzi-Lepri; bruno ledergerber; Schlomo Staszewski; Luc Perrin; Veronica Miller; Patrick Francioli; Hansjakob Furrer; Manuel Battegay; Pietro Vernazza; Enos Bernasconi; Huldrych Günthard; Bernard Hirschel; Andrew N Phillips; Amalio Telenti
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.
AIDS (London, England) 2002;16(14):1967-9.
2002: Ole Kirk; Peter Reiss; Caterina Uberti-Foppa; Markus Bickel; Jan Gerstoft; Christian Pradier; Ferdinand W N M Wit; bruno ledergerber; Jens D Lundgren; Hansjakob Furrer
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Annals of internal medicine 2002;137(4):239-50.
2002: Veronica Miller; Andrew N Phillips; Bonaventura Clotet; Amanda Mocroft; bruno ledergerber; Ole Kirk; Vidar Ormaasen; Panagiotis Gargalianos-Kakolyris; STEFANO VELLA; Jens D Lundgren
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts.
The Journal of infectious diseases 2002;186(2):189-97.
2002: Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; bruno ledergerber; François Dabis; Dominique Costagliola; Antonella d'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Hogg Robert; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Lancet 2002;360(9327):119-29.
2002: Milos Opravil; bruno ledergerber; Hansjakob Furrer; Bernard Hirschel; Alexander Imhof; Serge Gallant; Thomas Wagels; Enos Bernasconi; Fabian Meienberg; Martin Rickenbach; Rainer Weber
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /l.
AIDS (London, England) 2002;16(10):1371-81.
2002: Milos Opravil; Bernard Hirschel; Adriano Lazzarin; Hansjakob Furrer; Jean-Philippe Chave; Sabine Yerly; Leslie Bisset; Marek Fischer; Pietro Vernazza; Enos Bernasconi; Manuel Battegay; bruno ledergerber; Huldrych Günthard; Colin Howe; Rainer Weber; Luc Perrin
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.
The Journal of infectious diseases 2002;185(9):1251-60.
2002: Patrick Taffé; Martin Rickenbach; Bernard Hirschel; Milos Opravil; Hansjakob Furrer; Pascal Janin; Florence Bugnon; bruno ledergerber; Thomas Wagels; Philippe Sudre
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study.
AIDS (London, England) 2002;16(5):747-55.
2002: Bernard Hirschel; Markus Flepp; Heiner C Bucher; Claudine Zellweger; Amalio Telenti; Thomas Wagels; Enos Bernasconi; bruno ledergerber
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort.
AIDS (London, England) 2002;16(3):381-5.
2002: Jens D Lundgren; Amanda Mocroft; José M Gatell; bruno ledergerber; Antonella d'Arminio Monforte; Philippe Hermans; Frank-Detlef Goebel; Anders Blaxhult; Ole Kirk; Andrew N Phillips
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.
The Journal of infectious diseases 2002;185(2):178-87.
2001: Andrew N Phillips; Christian Pradier; Adriano Lazzarin; Bonaventura Clotet; Frank-Detlef Goebel; P Hermans; Francisco Antunes; bruno ledergerber; Ole Kirk; Jens D Lundgren
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients.
AIDS (London, England) 2001;15(18):2385-95.
2001: A N Phillips; Schlomo Staszewski; R Weber; O Kirk; Patrick Francioli; V Miller; P Vernazza; J D Lundgren; bruno ledergerber
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
JAMA : the journal of the American Medical Association 2001;286(20):2560-7.
2001: Christine Zinkernagel; Patrick Taffé; Martin Rickenbach; R Amiet; bruno ledergerber; A C Volkart; U Rauchfleisch; A Kiss; V Werder; Pietro Vernazza; Manuel Battegay
Importance of mental health assessment in HIV-infected outpatients.
Journal of acquired immune deficiency syndromes (1999) 2001;28(3):240-9.
2001: Jacques Fellay; karim boubaker; bruno ledergerber; Enos Bernasconi; Hansjakob Furrer; M Battegay; Bernard Hirschel; Pietro Vernazza; Patrick Francioli; Gilbert Greub; Markus Flepp; Amalio Telenti
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study.
Lancet 2001;358(9290):1322-7.
2001: A C Friedl; bruno ledergerber; Markus Flepp; Bernard Hirschel; Amalio Telenti; Hansjakob Furrer; Heiner C Bucher; Enos Bernasconi; Rainer Weber
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study.
AIDS (London, England) 2001;15(14):1793-800.
2001: E Bernasconi; J Jost; bruno ledergerber; Bernard Hirschel; Patrick Francioli; P Sudre
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000.
Swiss medical weekly 2001;131(29-30):433-7.
2001: Georg A Funk; M Fischer; Beda Joos; Milos Opravil; Huldrych Günthard; bruno ledergerber; Sebastian Bonhoeffer
Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells.
Journal of acquired immune deficiency syndromes (1999) 2001;26(5):397-404.
2001: bruno ledergerber; A Mocroft; Peter Reiss; Hansjakob Furrer; Ole Kirk; M Bickel; Caterina Uberti-Foppa; Christian Pradier; Antonella d'Arminio Monforte; M M Schneider; Jens D Lundgren
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
The New England journal of medicine 2001;344(3):168-74.
2000: Jörg Schüpbach; Zuzana Tomasik; David Nadal; bruno ledergerber; Markus Flepp; Milos Opravil; Jürg Böni
Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure.
International journal of antimicrobial agents 2000;16(4):441-5.
2000: Gilbert Greub; bruno ledergerber; Manuel Battegay; P Grob; Luc Perrin; Hansjakob Furrer; Philippe Burgisser; Peter Erb; Katia Boggian; Jean-Claude Piffaretti; Bernard Hirschel; Pascal Janin; Patrick Francioli; Markus Flepp; Amalio Telenti
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
Lancet 2000;356(9244):1800-5.
2000: P Durrer; Reinhard Zbinden; Felix Fleisch; Martin Altwegg; bruno ledergerber; H Karch; Rainer Weber
Intestinal infection due to enteroaggregative Escherichia coli among human immunodeficiency virus-infected persons.
The Journal of infectious diseases 2000;182(5):1540-4.
2000: Olivier T Rutschmann; Pietro L Vernazza; Heiner C Bucher; Milos Opravil; bruno ledergerber; Amalio Telenti; RP Malinverni; Enos Bernasconi; Catherine Fagard; Dominique Leduc; Luc Perrin; Bernard Hirschel
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(14):2145-51.
2000: Hansjakob Furrer; Amalio Telenti; M Rossi; bruno ledergerber
Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(10):1409-12.
2000: bruno ledergerber; Markus Flepp; Jürg Böni; Zuzana Tomasik; RW Cone; Ruedi Lüthy; Jörg Schüpbach
Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.
The Journal of infectious diseases 2000;181(4):1280-8.
1999: bruno ledergerber; Matthias Egger; V Erard; Rainer Weber; Bernard Hirschel; Hansjakob Furrer; Manuel Battegay; Pietro Vernazza; Enos Bernasconi; Milos Opravil; D Kaufmann; P Sudre; Patrick Francioli; Amalio Telenti
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
JAMA : the journal of the American Medical Association 1999;282(23):2220-6.
1999: Daniel Paris; bruno ledergerber; R Weber; J Jost; Markus Flepp; Milos Opravil; C Ruef; S Zimmerli
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
AIDS research and human retroviruses 1999;15(18):1631-8.
1999: Antonio Chiesi; Amanda Mocroft; L G Dally; Veronica Miller; Christine Katlama; bruno ledergerber; C Pedersen; Andrew N Phillips; Romano Arcieri; Jens D Lundgren
Regional survival differences across Europe in HIV-positive people: the EuroSIDA study.
AIDS (London, England) 1999;13(16):2281-8.
1999: Rainer Weber; Lisanne Christen; M Loy; S Schaller; S Christen; C R Joyce; U Ledermann; bruno ledergerber; R Cone; Ruedi Lüthy; Misha Cohen
Randomized, placebo-controlled trial of Chinese herb therapy for HIV-1-infected individuals.
Journal of acquired immune deficiency syndromes (1999) 1999;22(1):56-64.
1999: Christine Zinkernagel; bruno ledergerber; Manuel Battegay; RW Cone; Pietro Vernazza; Bernard Hirschel; Milos Opravil
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study.
AIDS (London, England) 1999;13(12):1587-9.
1999: R Weber; bruno ledergerber; R Zbinden; M Altwegg; G E Pfyffer; M A Spycher; J Briner; L Kaiser; Milos Opravil; C Meyenberger; M Flepp
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study.
Archives of internal medicine 1999;159(13):1473-80.
1999: bruno ledergerber; Amalio Telenti; Matthias Egger
Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study.
BMJ (Clinical research ed.) 1999;319(7201):23-4.
1999: Amanda Mocroft; Ole Kirk; SE Barton; M Dietrich; R Proenca; Robert Colebunders; Christian Pradier; A dArminio Monforte; bruno ledergerber; Jens D Lundgren
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group.
AIDS (London, England) 1999;13(8):943-50.
1999: Gerrit Jan Weverling; Amanda Mocroft; bruno ledergerber; Ole Kirk; J Gonzáles-Lahoz; A d'Arminio Monforte; R Proenca; Andrew N Phillips; Jens D Lundgren; P Reiss
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
Lancet 1999;353(9161):1293-8.
1999: J Evison; J Jost; bruno ledergerber; L Jost; Florian Strasser; R Weber
HIV-associated non-Hodgkin's lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy.
AIDS (London, England) 1999;13(6):732-4.
1999: bruno ledergerber; Matthias Egger; Milos Opravil; Amalio Telenti; Bernard Hirschel; Manuel Battegay; Pietro Vernazza; P Sudre; Markus Flepp; Hansjakob Furrer; Patrick Francioli; Rainer Weber
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.
Lancet 1999;353(9156):863-8.
1999: C Junghans; bruno ledergerber; P Chan; R Weber; Matthias Egger
Sex differences in HIV-1 viral load and progression to AIDS. Swiss HIV Cohort Study.
Lancet 1999;353(9152):589; author reply 590-1.
1998: RW Cone; P Gowland; Milos Opravil; PJ Grob; bruno ledergerber
Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection. Swiss HIV Cohort Study.
AIDS (London, England) 1998;12(17):2253-60.
1998: bruno ledergerber; Matthias Egger; M Rickenbach; R Weber
Poverty and prognosis of HIV infection in Switzerland. Swiss HIV Cohort Study.
AIDS (London, England) 1998;12(14):1933-4.
1998: M Opravil; M Rickenbach; bruno ledergerber
[The Swiss HIV Cohort Study--a link between clinical research and medical practice].
Therapeutische Umschau. Revue thérapeutique 1998;55(5):329-34.
1997: Michael Burke; Israel Yust; Christine Katlama; Nurith Vardinon; N Clumeck; A J Pinching; bruno ledergerber; J M Gatell; Antonio Chiesi; S E Barton; Jens D Lundgren; C Pedersen
Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(12):876-82.
1997: J D Lundgren; A N Phillips; STEFANO VELLA; C Katlama; bruno ledergerber; A M Johnson; P Reiss; J Gatell; Nathan Clumeck; M Dietrich; Thomas Benfield; Jens Ole Nielsen; C Pedersen
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(3):153-60.
1997: P Sudre; H Rieder; S Bassetti; Bernard Hirschel; bruno ledergerber; D Malvy
[Tuberculin test, antitubercular chemoprophylaxis and incidence of tuberculosis in a Swiss HIV cohort study].
Revue d'épidémiologie et de santé publique 1997;45(2):171-3.
1997: Amanda Mocroft; J D Lundgren; A d'Armino Monforte; bruno ledergerber; S E Barton; STEFANO VELLA; C Katlama; J Gerstoft; C Pedersen; Andrew N Phillips
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.
International journal of epidemiology 1997;26(2):400-7.
1996: M Schmid; W Twisselmann; B J Jacquat; bruno ledergerber; Manuel Battegay; Matthias Egger
[Sex differences in disease course: analysis of the Swiss HIV cohort study].
Schweizerische medizinische Wochenschrift 1996;126(51-52):2234-6.
1996: P Sudre; H Rieder; S Bassetti; Bernard Hirschel; bruno ledergerber; D Malvy
[HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
Schweizerische medizinische Wochenschrift 1996;126(47):2007-12.
1996: P Sudre; Bernard Hirschel; J M Gatell; S Schwander; STEFANO VELLA; C Katlama; bruno ledergerber; A d'Arminio Monforte; F D Goebel; P O Pehrson; C Pedersen; J D Lundgren
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1996;77(4):322-8.
1996: Heiner C Bucher; K Gyr; bruno ledergerber; P Sudre
Incidence of disseminated histoplasmosis in HIV-infected patients in Switzerland.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(4):417-8.
1996: P Sudre; Bernard Hirschel; L Toscani; bruno ledergerber; Hans L Rieder
Risk factors for tuberculosis among HIV-infected patients in Switzerland. Swiss HIV Cohort Study.
The European respiratory journal 1996;9(2):279-83.
1995: Jens D Lundgren; S E Barton; C Katlama; bruno ledergerber; J González-Lahoz; A J Pinching; R Proenca; R Hemmer; Court Pedersen; Andrew N Phillips
Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe.
Archives of internal medicine 1995;155(8):822-8.
1995: Matthias Egger; W Twisselmann; bruno ledergerber
Differences in progression of HIV infection between men and women.
BMJ (Clinical research ed.) 1995;310(6984):941.
1994: Jan von Overbeck; Matthias Egger; G D Smith; M Schoep; bruno ledergerber; Hansjakob Furrer; RP Malinverni
Survival in HIV infection: do sex and category of transmission matter? Swiss HIV Cohort Study.
AIDS (London, England) 1994;8(9):1307-13.
1994: J D Lundgren; C Pedersen; N Clumeck; J M Gatell; A M Johnson; bruno ledergerber; STEFANO VELLA; A Phillips; J O Nielsen
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group.
BMJ (Clinical research ed.) 1994;308(6936):1068-73.
1994: J D Lundgren; A N Phillips; C Pedersen; N Clumeck; J M Gatell; A M Johnson; bruno ledergerber; STEFANO VELLA; J O Nielsen
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.
JAMA : the journal of the American Medical Association 1994;271(14):1088-92.
1994: bruno ledergerber; Jan von Overbeck; Matthias Egger; Ruedi Lüthy
The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics.
Sozial- und Präventivmedizin 1994;39(6):387-94.
1993: Huldrych Günthard; Milos Opravil; bruno ledergerber; K Olsson; M Vogt; Walter Fierz; Ruedi Lüthy
[The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons].
Deutsche medizinische Wochenschrift (1946) 1993;118(20):737-45.
1993: M Zwahlen; bruno ledergerber
Estimating HIV prevalence in Switzerland.
AIDS (London, England) 1993;7(1):132-3.
1991: R Weber; bruno ledergerber; M Opravil
Treating drug misuse helps in HIV.
Nursing times 1991;87(2):10.
1990: R Weber; bruno ledergerber; Milos Opravil; W Siegenthaler; R Lüthy
Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.
BMJ (Clinical research ed.) 1990;301(6765):1362-5.
1990: Milos Opravil; Rainer Weber; bruno ledergerber; Rudolf Speich; W Siegenthaler; Ruedi Lüthy
Compliance and laboratory data predict relapse rate of Pneumocystis carinii pneumonia during prophylaxis with aerosol pentamidine.
Klinische Wochenschrift 1990;68(8):397-402.
1989: J Brühwiler; Ruedi Lüthy; Helen I Joller-Jemelka; bruno ledergerber; Walter Fierz; W Siegenthaler; PJ Grob
[The natural history and laboratory parameters of HIV infection].
Deutsche medizinische Wochenschrift (1946) 1989;114(26):1015-20.
1988: PJ Grob; Helen I Joller-Jemelka; Ruedi Lüthy; M Täuber; bruno ledergerber; J Brühwiler; Walter Fierz
[HIV serological parameters in the prognosis and follow-up assessment of an HIV infection].
Schweizerische medizinische Wochenschrift 1988;118(2):58-64.
1987: Ruedi Lüthy; bruno ledergerber; M Täuber; W Siegenthaler
Prevalence of HIV antibodies among prostitutes in Zürich, Switzerland.
Klinische Wochenschrift 1987;65(6):287-8.
1987: J Blaser; R Lüthy; S Rietiker; bruno ledergerber; M G Täuber
Prevalence of HIV antibodies in groups at risk in Zürich, Switzerland.
Klinische Wochenschrift 1987;65(5):245-6.
1986: J Jost; bruno ledergerber; M G Täuber
[The HIV-antibody positive patient in general practice. Guidelines for rational diagnosis and treatment].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1986;75(48):1454-7.
1985: M Vogt; Ruedi Lüthy; T Ferber; bruno ledergerber; Jörg Schüpbach; M Täuber; W Siegenthaler
[HTLV-III antibodies and risk factors for healthy homosexuals in Zurich].
Schweizerische medizinische Wochenschrift 1985;115(49):1777-8.
1985: Beda Joos; bruno ledergerber; Markus Flepp; J D Bettex; R Lüthy; W Siegenthaler
Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine.
Antimicrobial agents and chemotherapy 1985;27(3):353-6.
1985: bruno ledergerber; J D Bettex; Beda Joos; Markus Flepp; R Lüthy
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.
Antimicrobial agents and chemotherapy 1985;27(3):350-2.
1985: bruno ledergerber; J Blaser; R Lüthy
Computer-controlled in-vitro simulation of multiple dosing regimens.
The Journal of antimicrobial chemotherapy 1985;15 Suppl A():169-73.